<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang L</submitter><funding>Provincial Key Research and Development Program of Heilongjiang Province</funding><funding>Haiyan Fund of Harbin Medical University Cancer Hospital</funding><pagination>1316</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11515836</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Sentinel lymph node (SLN) biopsy (SLNB) is considered the gold standard for detecting SLN metastases in patients with invasive ductal breast cancer (IDC). However, SLNB is invasive and associated with several complications. Thus, this study aimed to evaluate the diagnostic performance of a non-invasive radiomics analysis utilizing 2-deoxy-2-[&lt;sup>18&lt;/sup>F]fluoro-d-glucose positron emission tomography/computed tomography (&lt;sup>18&lt;/sup>F-FDG-PET/CT) for assessing SLN metastasis in IDC patients.&lt;h4>Methods&lt;/h4>This retrospective study included 132 patients with biopsy-confirmed IDC, who underwent &lt;sup>18&lt;/sup>F-FDG PET/CT scans prior to mastectomy or breast-conserving surgery with SLNB. Tumor resection or SLNB was conducted within one-week post-scan. Clinical data and meta</pubmed_abstract><journal>BMC cancer</journal><pubmed_title>Can we skip invasive biopsy of sentinel lymph nodes? A preliminary investigation to predict sentinel lymph node status using PET/CT-based radiomics.</pubmed_title><pmcid>PMC11515836</pmcid><funding_grant_id>JJMS-2023-05</funding_grant_id><funding_grant_id>GA21C001</funding_grant_id><pubmed_authors>Ding H</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Xu S</pubmed_authors><pubmed_authors>Gao X</pubmed_authors><pubmed_authors>Wang K</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Can we skip invasive biopsy of sentinel lymph nodes? A preliminary investigation to predict sentinel lymph node status using PET/CT-based radiomics.</name><description>&lt;h4>Background&lt;/h4>Sentinel lymph node (SLN) biopsy (SLNB) is considered the gold standard for detecting SLN metastases in patients with invasive ductal breast cancer (IDC). However, SLNB is invasive and associated with several complications. Thus, this study aimed to evaluate the diagnostic performance of a non-invasive radiomics analysis utilizing 2-deoxy-2-[&lt;sup>18&lt;/sup>F]fluoro-d-glucose positron emission tomography/computed tomography (&lt;sup>18&lt;/sup>F-FDG-PET/CT) for assessing SLN metastasis in IDC patients.&lt;h4>Methods&lt;/h4>This retrospective study included 132 patients with biopsy-confirmed IDC, who underwent &lt;sup>18&lt;/sup>F-FDG PET/CT scans prior to mastectomy or breast-conserving surgery with SLNB. Tumor resection or SLNB was conducted within one-week post-scan. Clinical data and meta</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-07-15T17:45:25.599Z</modification><creation>2026-07-07T03:11:03.699Z</creation></dates><accession>S-EPMC11515836</accession><cross_references><pubmed>39455907</pubmed><doi>10.1186/s12885-024-13031-w</doi></cross_references></HashMap>